Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case-noncase study.
作者信息
Chouchana Laurent, Preta Laure-Hélène, Tisseyre Mylène, Terrier Benjamin, Treluyer Jean-Marc, Montastruc François
机构信息
Regional Center of Pharmacovigilance, Department of Pharmacology, Cochin Hospital, AP-HP, Centre-Université de Paris, Paris, France.
Regional Center of Pharmacovigilance, Department of Pharmacology, Cochin Hospital, AP-HP, Centre-Université de Paris, Paris, France.
出版信息
Kidney Int. 2021 May;99(5):1235-1236. doi: 10.1016/j.kint.2021.02.015. Epub 2021 Feb 26.
Abstract
摘要
相似文献
1
Kidney disorders as serious adverse drug reactions of remdesivir in coronavirus disease 2019: a retrospective case-noncase study.
Kidney Int. 2021 May;99(5):1235-1236. doi: 10.1016/j.kint.2021.02.015. Epub 2021 Feb 26.
2
Sinus Bradycardia in a Pediatric Patient Treated With Remdesivir for Acute Coronavirus Disease 2019: A Case Report and a Review of the Literature.
J Pediatric Infect Dis Soc. 2021 Oct 27;10(9):926-929. doi: 10.1093/jpids/piab029.
3
Efficacy of Remdesivir for COVID-19.
Discov Med. 2021 Mar-Apr;31(163):57-60.
4
Remdesivir as a broad-spectrum antiviral drug against COVID-19.
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):541-548. doi: 10.26355/eurrev_202101_24426.
5
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
6
COVID-19 updates: Remdesivir (Veklury) in high-risk outpatients with COVID-19.
Med Lett Drugs Ther. 2022 Feb 21;64(1644):31-32.
7
Assessment of adverse events associated with remdesivir use for coronavirus disease 2019 using real-world data.
Expert Opin Drug Saf. 2021 Dec;20(12):1559-1564. doi: 10.1080/14740338.2021.1962846. Epub 2021 Aug 5.
8
Liver and kidney function in patients with Covid-19 treated with remdesivir.
Br J Clin Pharmacol. 2021 Nov;87(11):4450-4454. doi: 10.1111/bcp.14831. Epub 2021 May 4.
9
Remdesivir for patients with COVID-19.
CMAJ. 2021 Jan 25;193(4):E125. doi: 10.1503/cmaj.202505. Epub 2021 Jan 6.
10
Update Alert 2: Remdesivir for Adults With COVID-19.
Ann Intern Med. 2021 Dec;174(12):W114-W115. doi: 10.7326/L21-0600. Epub 2021 Oct 5.
引用本文的文献
1
Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data.
Biomedicines. 2025 Jun 5;13(6):1387. doi: 10.3390/biomedicines13061387.
2
Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated.
Children (Basel). 2025 Mar 6;12(3):331. doi: 10.3390/children12030331.
3
Comprehensive analysis of adverse events associated with onasemnogene abeparvovec (Zolgensma) in spinal muscular atrophy patients: insights from FAERS database.
Front Pharmacol. 2025 Jan 7;15:1475884. doi: 10.3389/fphar.2024.1475884. eCollection 2024.
4
The Effects of Remdesivir and Dexamethasone on Renal Sirtuin-1 Expression and Renal Function in Male Rats.
Appl Biochem Biotechnol. 2024 Feb;196(2):632-642. doi: 10.1007/s12010-023-04529-3. Epub 2023 May 11.
5
Crosstalk between COVID-19 Infection and Kidney Diseases: A Review on the Metabolomic Approaches.
Vaccines (Basel). 2023 Feb 20;11(2):489. doi: 10.3390/vaccines11020489.
6
Effect of remdesivir on adverse kidney outcomes in hospitalized patients with COVID-19 and impaired kidney function.
PLoS One. 2023 Feb 27;18(2):e0279765. doi: 10.1371/journal.pone.0279765. eCollection 2023.
7
Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival.
Front Cell Infect Microbiol. 2022 Nov 24;12:1044770. doi: 10.3389/fcimb.2022.1044770. eCollection 2022.
8
Remdesivir does not affect mitochondrial DNA copy number or deletion mutation frequency in aged male rats: A short report.
PLoS One. 2022 Oct 26;17(10):e0271850. doi: 10.1371/journal.pone.0271850. eCollection 2022.
9
The potential of remdesivir to affect function, metabolism and proliferation of cardiac and kidney cells in vitro.
Arch Toxicol. 2022 Aug;96(8):2341-2360. doi: 10.1007/s00204-022-03306-1. Epub 2022 May 17.
10
Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS.
Front Pharmacol. 2022 Mar 25;13:692828. doi: 10.3389/fphar.2022.692828. eCollection 2022.
Zotero 插件